SEC Form 3 · accession 0001179110-16-029707
INVIVO THERAPEUTICS HOLDINGS CORP. · NVIV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pamela J Stahl
Officer — Chief Commercial Officer
Period of report
Sep 14, 2016
Accepted (ET)
Sep 16, 2016 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001292519
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.